Pursuant to Regulation 30 of SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.

Ref: NEPHROPLUS/SE/068 August 10, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Listing Centre Through: NEAPS Subject: Intimation of Schedule of Analyst / Institutional Investor meetings under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/ Madam, Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, as amended from time to time, we would like to inform you that the officials of the Company will be attending an Investor Conference as per the details below: Date & Time Event Host Nature of Meeting Place 13th & 14th August 2026 Non-Deal 1*1 / Group IIFL Capital Mumbai 9:00 AM IST Onwards Roadshow Meetings Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of Host / Company. The above disclosure is available on the website of the Company www.nephroplus.com Yours sincerely, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895